Gastrokines are stomach mucus cell-secreted proteins; 2 gastrokines are known, GKN1 and GKN2. Gastrokine expression is lost in gastric cancer, indicating a possible function in tumor suppression. We have identified a third gastrokine gene in mammals. METHODS: Gkn3 was characterized by studies of molecular structure, evolutionary conservation, and tissue expression as well as transcriptional/translational outcome in mouse genetic models of gastric pathology. The functional consequences of Gkn3 overexpression were evaluated in transfected cell lines. RESULTS: Gkn3 encodes a secreted (ϳ19 kilodalton) protein that is coexpressed with trefoil factor (Tff)2 in the distal stomach and discriminates a Griffinia simplicifolia lectin (GS)-IIpositive mucus neck cell (MNC) subpopulation in the proximal stomach. In humans, widespread homozygosity for a premature stop codon polymorphism, W59X, has likely rendered GKN3 non-functional. Population genetic analysis revealed an ancestral GKN3 read-through allele that predominates in Africans and indicates the rapid expansion of W59X among non-Africans during recent evolution. Mouse Gkn3 expression is strongly up-regulated in (Tff2-deficient) gastric atrophy, a pre-cancerous state that is typically associated with Helicobacter pylori and marks a non-proliferative, GS-II positive lineage with features of spasmolytic polypeptide-expressing metaplasia (SPEM). Gkn3 overexpression inhibits proliferation in gastric epithelial cell lines, independently of incubation with recombinant human TFF2 or apoptosis. CONCLU-SIONS: Gkn3 encodes a novel, functionally distinct gastrokine that is overexpressed and might restrain epithelial cell proliferation in gastric atrophy. Spread of the human GKN3 stop allele W59X might have been selected for among non-Africans because of its effects on pre-neoplastic outcomes in the stomach.
I t is well established that infection with the bacterium
Helicobacter pylori initiates the chronic inflammation ultimately leading to most cases of intestinal-type gastric cancer. Although H pylori infection is widespread, only a small proportion of infected individuals (ϳ3/10,000 individuals per year or 2.1% for lifetime infection) eventually develop adenocarcinoma. 1 Varied susceptibility to H pylori is not well understood, although polymorphisms in host genetic factors such as the proinflammatory cytokines interleukin-1␤, interleukin-8, and tumor necrosis factor-␣ may partly explain the paradox. 2, 3 Other risk factors influencing the outcome of H pyloriinitiated pathology include bacterial cytotoxin heterogeneity, diet, and geographic differences, in particular, the phenomenon of decreased gastric cancer incidence in Africa compared with other regions where H pylori is endemic. 4 This discrepancy partially has been attributed to helminth co-infection that likely modifies the characteristic proinflammatory type 1 T-helper 1 cell response, to a T-helper 2-predominant response, 5 typified by the release of noninflammatory cytokines and reduced incidence of H pyloriassociated glandular atrophy, an early marker of cancer development. The identification of novel genes regulated by H pylori in vivo, particularly those contributing to these early stages of neoplasia, would facilitate improved understanding of the differential susceptibility to this pathogen.
Gastrokines are a family of genes encoding stomach-specific secreted proteins consisting of 2 known members: Gastrokine (GKN)1 6 and GKN2. 7 Gastrokine expression is coordinately down-regulated in H pylori infection and is frequently lost in gastric cancer. 8, 9 Collectively, these studies argue that gastrokines participate in the host response to H pylori and also may function as gastric tumor-suppressor genes. 7 Although their mode of action remains unclear, the recent demonstration of a GKN2/trefoil factor (TFF)1 heterodimer in gastric mucus suggests that gastrokines may regulate the extracellular function of TFFs. 10 An unusual structural feature of gastrokine proteins is the BRICHOS domain, a 100-residue motif of likely functional significance that in other instances has been linked to respiratory distress, dementia, and cancer. 11 From an in silico screen for novel BRICHOS proteins in the mouse we have identified a third gastrokine gene in mammals. Gkn3 encodes a secreted (ϳ19 kilodalton) protein, co-expressed with, but not binding, Trefoil factor (Tff)2 in normal gastric epithelium and overexpressed in gastric atrophy, where it likely modulates epithelial cell proliferation. Finally, we show that human GKN3 has become nonfunctional during recent evolution and, using population genetic evidence, propose adaptive gene loss in response to geographically varied selective pressures. 
Materials and Methods

Mice
Tissue Sources and Genotyping
Genomic DNA was obtained from 72 patients of mixed ethnicity undergoing routine gastroscopy in accordance with Melbourne Health Human Research Ethics Committee approval (project 2004:176) and from 4 adult chimpanzees. Single nucleotide polymorphism haplotypes were determined using the iPLEX MassARRAY platform (Sequenom) as described. 14 Full details are provided in the Supplementary Materials and Methods section. Relevant single nucleotide polymorphisms were verified by direct sequencing as described. 15 
Bioinformatics
Protein sequence alignments were generated using the ClustalW2 tool (available: http://www.ebi.ac.uk/ tools/clustalw2/). 16 Human/mouse genomic alignments were performed using Genome Vista (available: http:// pipeline.lbl.gov/cgi-bin/gateway2). Regions aligned were as follows: human, NCBI build 36.1 (chromosome 2: 69,000,721-69,035,027); mouse, NCBI build 37 (chromosome 6: 87,338,036 -87,356,169). Human gene predictions used the CONTRAST 17 track integrated into the UCSC genome browser (available: http://genome.ucsc. edu/). Signal peptide sequences were predicted using SignalP_3.0 (available: http://www.cbs.dtu.dk/services/ SignalP/). 18 N-linked glycosylation sites were predicted using NetNGlyc_1.0 (available: http://www.cbs.dtu.dk/ services/NetNGlyc/). Transmembrane helices were predicted using TMHMM_v2.0 (available: http://www.cbs. dtu.dk/services/TMHMM/).
Gene Expression
Total RNA was isolated from tissue and cell lines using Trizol (Invitrogen, Carlsbad, CA), and contaminant genomic DNA was removed with DNA-free reagents (Ambion, Austin, TX). Rapid amplification of complementary DNA ends (RACE), degenerate polymerase chain reaction (PCR), semiquantitative nested reverse-transcription (RT)-PCR including all primer sequences and cycling parameters are described in the Supplementary Materials and Methods section. Unless stated otherwise, primer sequences were designed using primer3 (available: http://frodo.wi.mit.edu/ primer3/). For quantitative RT-PCR (QRT-PCR), oligo-dT primed complementary DNA (cDNA) was synthesized from 3 g total RNA using Murine Moloney Leukaemia Virus reverse transcriptase (Promega, Madison, WI). QRT-PCR was performed on an ABI Prism 7500 Real-Time PCR System using SYBR green master mix (Applied Biosystems, Austin, TX). Relative gene expression values were obtained by normalization to the reference gene Rpl32 (mouse) or G (human) using the Ϫ2 ⌬⌬Ct method, where Ϫ2⌬⌬Ct ϭ ⌬Ct sample Ϫ ⌬Ct calibrator (Applied Biosystems). Northern blotting and hybridization were performed according to standard protocols. 19 A full-length Gkn3 cDNA was used to generate ␣-32 P (deoxycytidine triphosphate)-labeled probe with DNA polymerase I (Klenow) fragment (Promega).
Antibodies, Immunofluorescence, and Immunoblotting
Sources of primary antibodies and lectins were as follows: rabbit polyclonal anti-mouse Gkn3 (R1043-bleed3: custom; see Supplementary Materials and Methods section) diluted 1:2000; rabbit polyclonal antihuman TFF2 (6-4, custom) diluted 1:2000; mouse monoclonal anti-human Ki67 (DAKO, Glostrup, Denmark) diluted 1:100; Griffinia simplicifolia lectin II (GS-II) (EY Labs, San Mateo, CA) used at 10 g/mL; mouse monoclonal antihemagglutinin (anti-HA) (Cell Signaling, Danvers, MA, #2367) diluted 1:1000; rabbit polyclonal anti-␤-actin (Cell Signaling, #4970) diluted 1:3000; rabbit polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase (Abcam, Cambridge, MA, #ab9485) diluted 1:3000. Immunofluorescence staining of cultured cells was performed as described. 20 Immunohistochemistry with peroxidase detection was performed as described. 15 Immunofluorescence detection in cultured cells and tissue sections used fluorescent secondary antibodies as follows: donkey anti-rabbit immunoglobulin (Ig)G-Alexa Fluor 594; goat anti-mouse IgG Alexa Fluor 488; streptavidin Alexa Fluor 488 (Invitrogen Molecular Probes). Samples were mounted in Pro-Long Gold with 4=,6-diamidino-2-phenylindole (DAPI) counterstain (Invitrogen). Fluorescence images were captured using a Leica TCS SP2 laser scanning confocal microscope (Leica, Wetzlar, Germany). For immunoblotting, tissue protein extracts, cell lysates, and culture supernatants were size fractionated by 15% sodium dodecyl sulfate-polyacrylam-ide gel electrophoresis, transferred to nitrocellulose membranes (GE Healthcare, Little Chalfont, UK), and blocked in 5% nonfat milk powder/Tris-buffered saline, pH 7.4, 0.1% Tween-20. Membranes were incubated with primary antibodies overnight at 4°C. Detection was performed with anti-rabbit/anti-mouse IgG-horseradish-peroxidase conjugates (DAKO) and enhanced chemiluminescence reagents (GE Healthcare).
Mammalian Cell Culture, Constructs, and Transfection
For overexpression in cells, a Gkn3 full-length cDNA was N-terminal HA tagged and amino acid codon substitutions were created by site-directed mutagenesis. Full details are provided in the Supplementary Materials and Methods section. Modified cDNAs were isolated on SalI fragments and inserted into the compatible XhoI site of the pCAGGSNeo expression vector. AGS and MKN28 gastric epithelial cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 50 IU/mL penicillin, and 50 g/mL streptomycin (Invitrogen). MKN28 cells were transfected with 2 g linearized Gkn3 cDNA expression construct DNA using FuGENE HD (Roche, Indianapolis, IN). Forty-eight hours after transfection cells were split 1:10 and selected with 300 g/mL G418 (Sigma, St Louis, MO) for 2 weeks. G418-resistant colonies were cloned by limiting dilution. 21 Gkn3-expressing clones were identified by immunoblotting and maintained with 200 g/mL G418. For inhibition of nonsense-mediated decay (NMD), AGS cells were treated with 100 g/mL cycloheximide in dimethyl sulfoxide (Sigma) for 6 hours.
Proliferation and Apoptosis
For proliferation, cell lines were serum starved overnight then seeded in 6-well plates at 2 ϫ 10 5 cells/well in RPMI 1640 medium supplemented with 0.5% fetal bovine serum, 50 IU/mL penicillin, 50 g/mL streptomycin, and 200 g/mL G418. Recombinant human TFF2 was used at 50 g/mL in growth medium. Viable cell counts were performed by 0.4% trypan blue exclusion on a hemocytometer. For apoptosis, cells were stained with annexinV Alexa Fluor 488 conjugate (Invitrogen Molecular Probes) and propidium iodide according to the manufacturer's protocols. Apoptotic (annexinV-positive, propidium iodide-negative) cells were resolved on an LSRII flow cytometer (BD Biosciences, San Diego, CA) and analyzed (10,000 events) using FACS Diva software (BD Biosciences).
Results
A Screen for BRICHOS Proteins Reveals a Novel Gastrokine Gene
We have identified a third gastrokine paralogue using a computational screen in the mouse. We hypothesized that new family members can be detected on the premise of 2 criteria: (1) a conserved BRICHOS domain and (2) near-exclusive expression in stomach. To test this hypothesis we scanned the mouse genome for all known and predicted genes encoding BRICHOS domain-containing proteins in Ensembl (available: http://www. ensembl.org/). Supplementary Table 1 lists 10 candidate BRICHOS protein-encoding genes we retrieved, their respective genomic locations, and tissue-expression profiles. Gkn1/Gkn2 excepted, 7 of these genes are not expressed significantly in the stomach. One candidate, a Riken cDNA, 1190003M12Rik, showed a clear stomach expression signature (Supplementary Table 1 ) and was subjected to molecular characterization.
1190003M12Rik maps to mouse chromosome 6qD1 and displays tight linkage to the 2 known gastrokine genes ( Figure 1A ). Northern blotting revealed a single approximately 0.8-kb messenger RNA (mRNA) in stomach (Figure 1B) . This transcript, deduced by cloning and sequencing overlapping 5= and 3= RACE cDNAs ( Figure 1C ), is 0.75 kb in length, comprised of 6 short exons spanning 5.6 kb of genomic DNA, and transcribed in the opposite orientation to Gkn2. Within this transcript we identified an open reading frame sufficient to encode a 181-residue BRICHOS protein with a theoretical molecular weight of 19.6 kilodaltons ( Figure 1D and F). An upstream in-frame methionine (Ϫ10 residues) putatively generates an alternative, N-terminal-extended, 191-residue open reading frame with a molecular weight of 20.7 kilodaltons; however, a stronger Kozak 22 consensus surrounding the downstream methionine ( Figure 1E and F) makes it the likely initiator and true protein N-terminus. Comparative analysis of the 181-residue open reading frame revealed strong homology with Gkn1 and Gkn2, showing 70% and 65% sequence similarity in respective pair-wise comparisons (data not shown). Gkn1 and Gkn2 share 66% similarity (data not shown), with 46% overall similarity in a 3-way comparison ( Figure 1F ). These 3 BRICHOS proteins are of similar size (181-184 amino acids), contain 4 position-conserved cysteine residues that putatively secure tertiary structure via disulphide bonds ( Figure 1F) , and a consensus N-terminal signal peptide suggesting secretion (Supplementary Figure 1) . Unlike the other gastrokines, our novel protein differs in a tract of hydrophobic amino acids at the N-terminus, predicted to form a single-pass transmembrane helix ( Supplementary Figure 
Gkn3 Encodes a Stomach-Specific Secreted Protein Co-Expressed With TFF2
QRT-PCR (Figure 2A ) confirmed stomach-restricted Gkn3 expression. We raised a polyclonal antibody to the predicted Gkn3 C-terminus ( Figure 2B and Supplementary Materials and Methods section) and confirmed the expression of an approximately 19-kilodalton protein in gastric antrum and fundus extracts by immunoblotting ( Figure 2C ). Several higher-molecular-weight bands (19 -24 kilodaltons) were present, suggesting ei- ther N-terminal-extended isoforms or posttranslational modifications such as glycosylation, as predicted by our earlier bioinformatic analysis. Specificity of the antibody was verified by immunoblotting in Gkn3-overexpressing cell lines ( Figure 2D ). Gkn3 mRNA/protein abundance is significantly higher in antrum than in fundus, contrasting with Gkn1/Gkn2, showing equivalent regional expression (Figure 2A) . To investigate the functional significance of this difference we examined the cellular distribution of Gkn3 in stomach. Immunofluorescence revealed strong Gkn3-specific staining in mucus cells at the base of the antral glands, and Brunner's glands of the duodenum ( Figure 2E ). Consistent with mRNA data, Gkn3 staining was less abundant in fundus and restricted to the mucus neck cell (MNC) region ( Figure 2F ). Double staining revealed colocalization of Gkn3 and the MNC marker, GS-II, in the lower (basal) neck region whereas GS-II-positive cells in the upper (lumenal) neck cell region were not Gkn3 immunoreactive. Conversely, an antibody to a second MNC marker, Tff2, 23 stained GS-II-positive cells in the upper, but not the lower, neck cell region ( Figure 2F ). That is, Gkn3 and Tff2 are expressed discordantly in MNCs, discriminating respective GS-II-positive, and spatially polarized, MNC subpopulations in the fundus.
Striking similarities were noted in the distribution of Gkn3 and Tff2 in antral mucus cells and Brunner's glands ( Figure 2E ) indicating co-expression. This is intriguing because co-expression and heterodimer formation occurs between GKN2 and TFF1. 10 Accordingly, we hypothesized that Gkn3 is an unrecognized binding partner for Tff2, but could not show co-immunoprecipitation of Gkn3 and Tff2 in transfected cells (Supplementary Figure 4 and Supplementary Materials and Methods) or mouse gastric lysates (data not shown). The GKN2-TFF1 heterodimer is formed by an intramolecular disulphide bond linking unpaired cysteines in the respective monomers. 10, 24 Neither Gkn3 nor Tff2 has unpaired cysteines and, taken together with our co-immunoprecipitation data, we conclude that Gkn3 is co-expressed, but does not dimerize with Tff2.
Gkn3 staining was observed in secretory granules in MNCs ( Figure 3A, i) and antral mucus cells ( Figure 3A , ii), whereas extracellular staining was evident in mucus overlying surface and pit cells ( Figure 3A, iii) . Immunoblotting of gastric juice supernatants revealed specific Gkn3 bands (19 -24 kilodaltons) and a processed 17-kilodalton form ( Figure 3B ), suggesting active secretion of Gkn3 into mucus. To confirm this and investigate the role of the BRICHOS domain in this process, we examined the trafficking of N-terminal HA-tagged Gkn3 fusion proteins containing either wild-type Gkn3, mutated BRICHOS sequence with glycine substituted for cysteine (HA-Gkn3 C137G ), or mutated C-terminus (HA-Gkn3 C171G ) in stable overexpressing MKN28 cells using anti-HA/antiGkn3 antibodies that respectively discriminate the Nand C-terminus ( Figure 3C ). Immunoblotting confirmed overexpression of Gkn3 protein in cell lysates, which rapidly accumulated to high levels in growth medium ( Figure 3D, Supplementary Figure 5) , thus confirming secretion. HA-tagged Gkn3 was detected in cell lysates but not in growth medium ( Figure 3D ), consistent with signal peptide cleavage before secretion. By comparison, the putatively misfolded mutant Gkn3 proteins were almost undetectable in growth medium, yet abundantly expressed in corresponding cell lysates, suggesting compromised secretion ( Figure 3E ). These mutant proteins instead accumulated in the cytoplasm as unprocessed HA-tagged precursors ( Figure 3F ). Therefore, Gkn3 is processed and secreted from gastric epithelial cells dependent on correct tertiary structure, suggesting an important extracellular function in vivo.
Mammalian Conservation and Human Gene Loss
Gkn3 shows strong evolutionary conservation, with 5 mammalian orthologues sharing 58% amino acid identity and strict preservation of structural features including all cysteine residues and N-terminal transmembrane helix ( Figure 4A ). These orthologues show conserved linkage to Gkn1/Gkn2 and are expressed in the stomach as inferred by expressed sequence tag (EST) evidence (data not shown) or by cloning full-length cDNA ( Figure 1C ). Genome resources do not annotate a human GKN3 orthologue or ESTs supporting its existence. By alignment of mouse Gkn3 genomic sequence with the human genome we mapped human GKN3 to chromosome 2p14, in a region of conserved linkage to GKN2 ( Figure 4B ). In agreement with absent EST evidence, GKN3 expression could not be detected in 6 human gastric biopsy specimens tested, although GKN1 and GKN2 were highly expressed in each case (data not shown). This suggested that GKN3 has been inactivated in humans but not in other mammals.
To elucidate this apparent loss of function, we determined the likely mRNA structure and open reading frame for human GKN3 by gene prediction. To confirm the orthology we aligned the predicted open reading frame against that of other Gkn3 orthologues ( Figure  4A ). Unlike other orthologues, human GKN3 contains a nonsense single nucleotide polymorphism (single nucleotide polymorphism; rs10187256) in exon 3, substituting a premature stop codon for a read-through tryptophan at position 59 (W59X) (Figure 4B and C) . Nonsense mutations are deleterious and usually eliminated at the mRNA level by NMD. 25 We hypothesized that W59X triggers NMD, leading to the degradation of GKN3 mRNA. Accordingly, treatment of gastric AGS cells (homozygous for W59X) with the NMD inhibitor, cycloheximide, resulted in the rapid accumulation of GKN3 mRNA ( Figure  4D ) without affecting GKN1/GKN2 expression (data not shown). GKN3 is therefore silenced by NMD, suggesting a mechanism for loss of function in humans.
We next examined the worldwide distribution of the W59X stop allele ( Figure 5A ) in geographically separated populations using HapMap data (available: http://www. hapmap.org/). This included 114 Utah residents with European ancestry, 116 Yoruba from Ibadan, Nigeria, 90 Han Chinese from Beijing, and 90 Japanese from Tokyo. In agreement with our expression analysis, W59X is near fixation in Caucasians with European ancestry and fixed in East Asians (Han Chinese from Beijing and Japanese from Tokyo). By contrast, W59X occurs at a much lower frequency in Africans (Yoruba from Ibadan, Nigeria), in whom a majority of haplotypes are represented by the ancestral (G) read-through allele, for which 50% of individuals are homozygous (G/G). Sequencing of the chimpanzee orthologue (n ϭ 4) revealed an identical (G/G) read-through allele ( Figure 5B ), placing the origin of W59X in ancestral humans after the divergence from nonhuman primates. This prompted us to determine whether individuals carrying at least one ancestral readthrough allele might retain functional GKN3. We genotyped 72 Australian individuals of mixed ethnicity from Melbourne finding that, similar to other non-African populations, W59X is near fixation ( Figure 5A ). Despite low frequency of the read-through allele, 2 homozygous and 6 heterozygous individuals were identified ( Figure  5B ), providing an opportunity to examine GKN3 expression in relation to W59X. However, only marginal mRNA expression was found in gastric tissue from these individuals and protein could not be shown clearly (data not shown). Nonetheless, our results show evidence of a prehistoric selective sweep that increased the frequency of W59X to fixation in most non-Africans. This argues that loss of GKN3 may have been adaptive in recent human evolution.
Gkn3 Is Overexpressed in Gastric Atrophy Preceding Cancer
The identification of selection pressures driving gene loss, as argued for GKN3, is facilitated greatly if the function of the locus in question is known. Functional consequences of other human-specific gene loss events have been elucidated successfully by phenotype analysis of mice carrying deletions in the corresponding functional orthologues. 26, 27 Because Gkn3 knockout mice are not yet available, Gkn3 expression instead was quantified in mouse models of gastric pathology showing hypertrophy, atrophy, or tumorigenesis. HϩKϩ ATPase-␤ subunit (HK-␤)-deficient mice develop gastrin-dependent fundic atrophic hypertrophy, 28 whereas the gp130 Y757F/Y757F (gp130 F/F ) mutant is a model for gastric tumorigenesis displaying similar preneoplastic histopathology to human adenocarcinoma. 13, 29 Disruption of Tff2 in gp130 F/F mice results in fundic glandular atrophy, characterized by loss of parietal and zymogenic cells, expansion of an MNC-like lineage, and increased Th1-type cytokine re- Figure 6B ). Double staining with GS-II showed that Gkn3 overexpression in fundic atrophy and hypertrophy was caused by the expanded MNC-like population ( Figure 6D-F) . Conversely, Gkn1/Gkn2 expression significantly decreased in atrophy ( Figure 6A ) and hypertrophy ( Figure 6C ), consistent with their specificity to depleted surface mucus/pit lineages. These data not only reveal a link between Gkn3 overexpression and atrophic mucus metaplasia, but also differential regulation to the other gastrokines in pathology, emphasizing the functional distinction of Gkn3.
Gkn3 Inhibits Gastric Epithelial Cell Proliferation Without Affecting Apoptosis
MNCs may represent a transitory lineage from which zymogenic cells arise. 30 Mucus metaplasia together with loss of zymogenic cells in the atrophic fundus of gp130 F/F /Tff2 Ϫ/Ϫ mice suggested perturbed differentiation of these lineages. Double staining showed Gkn3-positive MNCs and the Ki-67-positive isthmic proliferative zone clearly were separated in the nonatrophic fundus of wild-type and gp130 F/F mice, but partially merged in the atrophic gp130 F/F /Tff2 Ϫ/Ϫ fundus. Occasional Gkn3/Ki-67 double-positive cells were observed in the bases of gp130 F/F / Tff2 Ϫ/Ϫ fundic glands, consistent with altered differentiation ( Figure 7A and B) . To further evaluate Gkn3 overexpression in atrophic mucus metaplasia, specifically the impact on proliferation of gastric epithelial cells, we analyzed the growth curves of 4 independent Gkn3-overexpressing MKN28 clones with a high level of Gkn3 expression ( Figure 3D ). Growth strongly was attenuated in Gkn3-expressing clones at 48 and 96 hours (P Ͻ .05) after plating compared with empty vector clones ( Figure  7C ). We tested whether recombinant human TFF2 might affect the growth rate of Gkn3-transfected clones but no significant difference was found, although recombinant human TFF2 induced modest growth suppression in empty vector clones (P Ͻ .05) at 96 hours ( Figure 7C) . No difference in apoptosis between Gkn3-expressing and empty vector clones was observed, irrespective of recombinant human TFF2 treatment ( Figure 7D ), excluding increased programmed cell death as the mode of growth suppression by Gkn3 or TFF2. Collectively, these results show that Gkn3 inhibits gastric epithelial cell proliferation independently of TFF2 or apoptosis.
Discussion
From a screen of the mouse genome for novel BRICHOS proteins we have identified and characterized a novel member of the gastrokine family. Gkn3 encodes a secreted protein, suggesting an important extracellular function, which is highly expressed in the stomach epithelium where it likely regulates cellular proliferation.
The gastrokines are clustered tightly on mouse chromosome 6 and show conserved linkage in several mammals including humans. Interestingly, the 3 TFF genes are clustered similarly on human chromosome 21 with conserved linkage on mouse chromosome 17. 31 This observation may not be coincidental because GKN2 and TFF1 form a heterodimer, are co-expressed in the gastric epithelium, and may have co-dependent functions in vivo. 10, 24 Likewise, Gkn3 and Tff2 are co-expressed, at least in antral gland mucus cells and Brunner's gland cells.
In MNCs, Gkn3 expression is most pronounced in cells nearest the gland base, which also lack Tff2 expression, arguing that it marks a distinct and Tff2-negative MNC subpopulation, possibly zymogenic precursors. 30 In fundic atrophy Gkn3 protein marks an expanded MNC-like population reminiscent of spasmolytic polypeptide-expressing metaplasia, a precursor to more serious gastric pathology. 32 Gkn3 overexpression may contribute to this phenotype or be induced as a response-limiting pathology as our in vitro proliferation data suggest. In any event, Gkn3 and Tff2 proteins are unlikely to interact physically because unlike TFF1 and GKN2, neither contains an unpaired cysteine for disulphide-linked heterodimer formation, and immunoprecipitation using specific antibodies did not show an interaction.
Although conserved in mammals, GKN3 function has been lost in modern humans, possibly owing to the emergence of premature stop codon (W59X), and consequent NMD. We identified an ancestral read-through variant in at least one African population (Yoruba from Ibadan, Nigeria), occurring at high frequency. However, the low frequency of this ancestral GKN3 allele in nonAfricans, and resulting ascertainment bias masking its existence in human genome resources, may explain why Gkn3 has evaded detection until now. Although we could not show expression of ancestral GKN3 in the 2 informative individuals available to us, it remains possible that functional GKN3 persists in human populations not analyzed here.
A similar premature stop codon polymorphism has been reported at the CASP12 locus, where an active ancestral form in approximately 20% of individuals of African descent is functionally significant because it modulates endotoxin responsiveness. 33 Accordingly, Casp12-deficient mice show increased resistance to bacterial sepsis compared with wild-type controls. 26 This establishes a precedent for the spread of stop alleles in nonAfrican populations, suggesting that positive selection may have played a role. Likewise, the selective advantage of W59X in Caucasians and Asians, but not Africans, is inconsistent with neutrality and instead argues that functional GKN3 may have become a burden during recent evolution.
Why gene loss should apply only to GKN3, especially because the functional mouse orthologue has antiproliferative effects on gastric cancer cells, but not related gastrokines, is not entirely clear. Our data argue against redundancy with other family members, instead showing that Gkn3 is functionally distinct, being expressed in MNCs and antral glands rather than surface mucus cells, and differentially expressed in gastric pathologies. It is possible that GKN3 gene loss is related to this functional niche. Moreover, our findings implicate the host response to H pylori because Gkn3 is strongly up-regulated, whereas Gkn1 and Gkn2 are down-regulated after genetic induction of atrophy, or after H pylori infection in humans. 34 Although the function of Gkn3 remains to be substantiated formally, our results support a role in gastric epithelial atrophy and possibly the host response to H pylori. Identification of the selective forces that promoted loss of GKN3 in humans, and retention of an ancestral variant in Africans, would undoubtedly clarify its functional significance.
